GATE-101

N/A

Report date: 2025/06/09 14:19:35
NME

Base Information

Drug NameGATE-101
Drug Alias NameGATE-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 2 antagonistsMetabotropic glutamate receptor 3 antagonists
TargetsMetabotropic glutamate receptor 2Metabotropic glutamate receptor 3
Therapy Area/IndicationsDepressive Disorder, MajorDisorders of Excessive Somnolence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGate Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGate Neurosciences Inc
Active IndicationsDepressive Disorder, MajorDisorders of Excessive Somnolence
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A